Skip to main content

Peer Review reports

From: Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine

Original Submission
13 Apr 2020 Submitted Original manuscript
24 May 2020 Reviewed Reviewer Report
8 Jul 2020 Author responded Author comments - Zhou Tong
Resubmission - Version 2
8 Jul 2020 Submitted Manuscript version 2
10 Jul 2020 Reviewed Reviewer Report
16 Aug 2020 Author responded Author comments - Zhou Tong
Resubmission - Version 3
16 Aug 2020 Submitted Manuscript version 3
31 Aug 2020 Author responded Author comments - Zhou Tong
Resubmission - Version 4
31 Aug 2020 Submitted Manuscript version 4
2 Sep 2020 Author responded Author comments - Zhou Tong
Resubmission - Version 5
2 Sep 2020 Submitted Manuscript version 5
4 Sep 2020 Author responded Author comments - Zhou Tong
Resubmission - Version 6
4 Sep 2020 Submitted Manuscript version 6
Publishing
8 Sep 2020 Editorially accepted
21 Sep 2020 Article published 10.1186/s12920-020-00794-x

You can find further information about peer review here.

Back to article page